• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

武藏2号RNA结合蛋白在癌症上皮-间质转化中的潜在作用

Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT.

作者信息

Sun Jian, Sheng Weiwei, Ma Yuteng, Dong Ming

机构信息

Department of Gastrointestinal Surgery, The First Hospital, China Medical University, Shenyang, 110001, People's Republic of China.

出版信息

Onco Targets Ther. 2021 Mar 17;14:1969-1980. doi: 10.2147/OTT.S298438. eCollection 2021.

DOI:10.2147/OTT.S298438
PMID:33762829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7982713/
Abstract

Local invasion and distant metastasis are the key hallmarks in the aggressive progression of malignant tumors, including the ability of cancer cells to detach from the extracellular matrix overcome apoptosis, and disseminate into distant sites. It is generally believed that this malignant behavior is stimulated by epithelial-mesenchymal transition (EMT). Musashi (MSI) RNA-binding proteins, belonging to the evolutionarily conserved RNA-binding proteins (RBP) family, were originally discovered to regulate asymmetric cell division during embryonic development. Recently, Musashi-2 (MSI2), as a key member of MSI family, has been prevalently reported to be tightly associated with the advanced clinical stage of several cancers. Multiple oncogenic signaling pathways mediated by MSI2 play vital roles in EMT. Here, we systematically reviewed the detailed role and signal networks of MSI2 in regulating cancer development, especially in EMT signal transduction, involving EGF, TGF-β, Notch, and Wnt pathways.

摘要

局部侵袭和远处转移是恶性肿瘤侵袭性进展的关键标志,包括癌细胞从细胞外基质脱离、克服凋亡并扩散到远处部位的能力。一般认为,这种恶性行为是由上皮-间质转化(EMT)所激发的。武藏(MSI)RNA结合蛋白属于进化上保守的RNA结合蛋白(RBP)家族,最初被发现可在胚胎发育过程中调节不对称细胞分裂。最近,作为MSI家族的关键成员,武藏-2(MSI2)已被普遍报道与多种癌症的晚期临床阶段密切相关。由MSI2介导的多种致癌信号通路在EMT中发挥着至关重要的作用。在此,我们系统地综述了MSI2在调节癌症发展,特别是在EMT信号转导(涉及表皮生长因子、转化生长因子-β、Notch和Wnt信号通路)中的详细作用和信号网络。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df1b/7982713/6ffa57245ed5/OTT-14-1969-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df1b/7982713/83a8627bd79d/OTT-14-1969-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df1b/7982713/6ffa57245ed5/OTT-14-1969-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df1b/7982713/83a8627bd79d/OTT-14-1969-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df1b/7982713/6ffa57245ed5/OTT-14-1969-g0002.jpg

相似文献

1
Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT.武藏2号RNA结合蛋白在癌症上皮-间质转化中的潜在作用
Onco Targets Ther. 2021 Mar 17;14:1969-1980. doi: 10.2147/OTT.S298438. eCollection 2021.
2
Interplay between the RNA binding-protein Musashi and developmental signaling pathways.RNA 结合蛋白 Musashi 与发育信号通路之间的相互作用。
J Gene Med. 2020 Jan;22(1):e3136. doi: 10.1002/jgm.3136.
3
[Advances in research of Musashi2 in solid tumors].[实体瘤中Musashi2的研究进展]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Mar 20;42(3):448-456. doi: 10.12122/j.issn.1673-4254.2022.03.20.
4
Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.武藏RNA结合蛋白作为癌症驱动因素和新型治疗靶点
Clin Cancer Res. 2017 May 1;23(9):2143-2153. doi: 10.1158/1078-0432.CCR-16-2728. Epub 2017 Jan 31.
5
MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma.胶质母细胞瘤中 MSI2-TGF-β/TGF-β R1/SMAD3 正反馈调控。
Cancer Chemother Pharmacol. 2019 Aug;84(2):415-425. doi: 10.1007/s00280-019-03892-5. Epub 2019 Jun 27.
6
Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.Musashi2 通过 ZEB1-ERK/MAPK 信号促进胰腺癌中 EGF 诱导的 EMT。
J Exp Clin Cancer Res. 2020 Jan 17;39(1):16. doi: 10.1186/s13046-020-1521-4.
7
Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.人类癌蛋白Musashi-2 N端RNA识别基序1的晶体结构和溶液结构
Proteins. 2020 Apr;88(4):573-583. doi: 10.1002/prot.25836. Epub 2019 Oct 29.
8
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.Musashi-2(MSI2)支持转化生长因子-β(TGF-β)信号传导并抑制紧密连接蛋白以促进非小细胞肺癌(NSCLC)转移。
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):6955-60. doi: 10.1073/pnas.1513616113. Epub 2016 Jun 6.
9
RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.RNA 结合蛋白 MSI2 异构体在三阴性乳腺癌进展中的表达和调控。
J Exp Clin Cancer Res. 2020 May 24;39(1):92. doi: 10.1186/s13046-020-01587-x.
10
Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.转录组全谱分析揭示了 RNA 结合蛋白 MSI2 的靶标,以及 MSI2 的 RNA 结合活性对 IL-6 信号的影响。
J Biol Chem. 2018 Oct 5;293(40):15359-15369. doi: 10.1074/jbc.RA118.002243. Epub 2018 Aug 20.

引用本文的文献

1
Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2.Smad2与TGIF2协同作用,通过共同靶向SOX2促进胰腺癌的上皮-间质转化和癌症干细胞特性。
Int J Biol Sci. 2025 Jan 1;21(2):524-543. doi: 10.7150/ijbs.102381. eCollection 2025.
2
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.基于微小RNA和RNA结合蛋白的肝胆癌骨转移调控及潜在治疗策略
Cells. 2024 Nov 21;13(23):1935. doi: 10.3390/cells13231935.
3
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression.

本文引用的文献

1
Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.Musashi2 通过一种 novel ISYNA1-p21/ZEB-1 通路促进胰腺癌的进展。
J Cell Mol Med. 2020 Sep;24(18):10560-10572. doi: 10.1111/jcmm.15676. Epub 2020 Aug 11.
2
RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.RNA 结合蛋白 MSI2 异构体在三阴性乳腺癌进展中的表达和调控。
J Exp Clin Cancer Res. 2020 May 24;39(1):92. doi: 10.1186/s13046-020-01587-x.
3
Suppression of Musashi‑2 by the small compound largazole exerts inhibitory effects on malignant cells.
微星2(MSI2)通过调控Nemo样激酶(NLK)介导的上皮-间质转化(EMT)和磷脂酰肌醇-3激酶(PI3K)/蛋白激酶B(AKT)/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路来促进胰腺癌进展。
Cancer Cell Int. 2024 Aug 3;24(1):273. doi: 10.1186/s12935-024-03444-9.
4
Identification of ASMTL-AS1 and LINC02604 lncRNAs as novel biomarkers for diagnosis of colorectal cancer.鉴定 ASMTL-AS1 和 LINC02604 lncRNAs 作为结直肠癌诊断的新型生物标志物。
Int J Colorectal Dis. 2024 Jul 19;39(1):112. doi: 10.1007/s00384-024-04692-x.
5
Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair.Musashi2通过调节DNA损伤修复影响肺癌放射敏感性的机制。
MedComm (2020). 2024 Apr 21;5(5):e548. doi: 10.1002/mco2.548. eCollection 2024 May.
6
Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.乔莱酮 B 通过调控 Musashi-2 蛋白抑制肝癌进展。
PLoS One. 2024 Apr 17;19(4):e0299920. doi: 10.1371/journal.pone.0299920. eCollection 2024.
7
Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition.癌症相关成纤维细胞中的Musashi-2通过旁分泌白细胞介素-6驱动的上皮-间质转化促进非小细胞肺癌转移。
Cell Biosci. 2023 Nov 8;13(1):205. doi: 10.1186/s13578-023-01158-5.
8
RNA-Binding Proteins in Bladder Cancer.膀胱癌中的RNA结合蛋白
Cancers (Basel). 2023 Feb 10;15(4):1150. doi: 10.3390/cancers15041150.
9
Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysis.武藏2(MSI2)在癌症患者中的预后价值:一项系统评价和荟萃分析。
Front Oncol. 2022 Dec 1;12:969632. doi: 10.3389/fonc.2022.969632. eCollection 2022.
10
Experimental and Clinical Biomarkers for Progressive Evaluation of Neuropathology and Therapeutic Interventions for Acute and Chronic Neurological Disorders.用于急性和慢性神经障碍的神经病理学和治疗干预的渐进性评估的实验和临床生物标志物。
Int J Mol Sci. 2022 Oct 3;23(19):11734. doi: 10.3390/ijms231911734.
小分子 largazole 通过抑制 Musashi-2 对恶性细胞发挥抑制作用。
Int J Oncol. 2020 May;56(5):1274-1283. doi: 10.3892/ijo.2020.4993. Epub 2020 Feb 19.
4
Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.肌球蛋白结合 RNA 结合蛋白敲低可降低三阴性乳腺癌的放射抵抗性,但增强细胞迁移和侵袭能力。
Int J Mol Sci. 2020 Mar 21;21(6):2169. doi: 10.3390/ijms21062169.
5
MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.微小 RNA-149 通过下调 MSI2 和抑制 PI3K/AKT 通路抑制卵巢癌的恶性表型。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):55-64. doi: 10.26355/eurrev_202001_19895.
6
Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling.Musashi2 通过 ZEB1-ERK/MAPK 信号促进胰腺癌中 EGF 诱导的 EMT。
J Exp Clin Cancer Res. 2020 Jan 17;39(1):16. doi: 10.1186/s13046-020-1521-4.
7
Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.Musashi2 通过 Notch1 信号通路促进 CD44v6+ 肝癌干细胞的维持。
J Exp Clin Cancer Res. 2019 Dec 30;38(1):505. doi: 10.1186/s13046-019-1508-1.
8
Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting MSI2.上调 microRNA-143-3p 通过靶向 MSI2 诱导甲状腺乳头状癌细胞凋亡并抑制其增殖、侵袭和迁移。
Exp Mol Pathol. 2020 Feb;112:104342. doi: 10.1016/j.yexmp.2019.104342. Epub 2019 Nov 15.
9
Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.长链非编码 RNA 01296/微小 RNA-143-3p/MSI2 轴在甲状腺癌发展中的新兴作用。
Biosci Rep. 2019 Nov 29;39(11). doi: 10.1042/BSR20182376.
10
SNP rs710886 A>G in long noncoding RNA PCAT1 is associated with the risk of endometriosis by modulating expression of multiple stemness-related genes via microRNA-145 signaling pathway.长链非编码RNA PCAT1中的单核苷酸多态性rs710886 A>G通过微小RNA-145信号通路调节多个干性相关基因的表达,与子宫内膜异位症的风险相关。
J Cell Biochem. 2020 Feb;121(2):1703-1715. doi: 10.1002/jcb.29406. Epub 2019 Oct 8.